Modified docetaxel, cisplatin, and fluorouracil (mDCF)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Modified docetaxel, cisplatin, and fluorouracil (mDCF), covering 2019-12-10 to 2019-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]